Advisory Committees; Tentative Schedule of Meetings for 2007, 78443-78445 [E6-22389]
Download as PDF
<![CDATA[
78443
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Notices
Title of Information Collection:
Medicaid Statistical Information
System.
Use: State data are reported by the
Federally mandated electronic process,
known as Medicaid Statistical
Information System (MSIS). These data
are the basis of actuarial forecasts for
Medicaid service utilization and costs;
of analysis and cost savings estimates
required for legislative initiatives
relating to Medicaid; and for responding
to requests for information from CMS
components, the Department, Congress
and other customers. Form Number:
CMS–R–284 (OMB#: 0938–0345).
Frequency: Quarterly.
Affected Public: State, Local or Tribal
Government.
Number of Respondents: 53.
Total Annual Responses: 212.
Total Annual Hours: 3,392.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
Written comments and
recommendations for the proposed
information collections must be mailed
or faxed within 30 days of this notice
directly to the OMB desk officer: OMB
Human Resources and Housing Branch,
Attention: Katherine Astrich, New
Executive Office Building, Room 10235,
Washington, DC 20503, Fax Number:
(202) 395–6974.
4), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–827–1220.
Dated: December 21, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E6–22233 Filed 12–28–06; 8:45 am]
The IOM,
at the request of the Commissioner,
undertook a study of the use of FDA’s
advisory committees. In its final report
in 1992, one of the IOM’s
recommendations was for FDA to adopt
a policy of publishing an advance yearly
schedule of its upcoming public
advisory committee meetings in the
Federal Register; FDA has implemented
this recommendation. The annual
publication of tentatively scheduled
advisory committee meetings will
provide both advisory committee
members and the public with the
opportunity, in advance, to schedule
attendance at FDA’s upcoming advisory
committee meetings. Because the
schedule is tentative amendments to
this notice will not be published in the
Federal Register. However, changes to
the schedule will be posted on the FDA
advisory committees’ Internet site
located at https://www.fda.gov/oc/
advisory/default.htm. FDA will
continue to publish a Federal Register
notice 15 days in advance of each
upcoming advisory committee meeting,
to announce the meeting (21 CFR 14.20).
The following list announces FDA’s
tentatively scheduled advisory
committee meetings for 2007. You may
also obtain up-to-date information by
calling the Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area).
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative
Schedule of Meetings for 2007
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
tentative schedule of forthcoming
meetings of its public advisory
committees for 2007. During 1991, at the
request of the Commissioner of Food
and Drugs (the Commissioner), the
Institute of Medicine (the IOM)
conducted a study of the use of FDA’s
advisory committees. In its final report,
one of the IOM’s recommendations was
for the agency to publish an annual
tentative schedule of its meetings in the
Federal Register. This publication
implements the IOM’s recommendation.
FOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF–
SUPPLEMENTARY INFORMATION:
TABLE 1.
Committee Name
Tentative Date(s) of Meeting(s)
Advisory Committee
10–Digit Information
Line Code
OFFICE OF THE COMMISSIONER
Pediatric Advisory Committee
April day(s) to be announced.
8732310001
Science Board to the Food and Drug Administration
June day(s) to be announced.
3014512603
Allergenic Products Advisory Committee
April 18, October 19.
3014512388
Blood Products Advisory Committee
April 26–27, August 16–17, December 13–14.
3014519516
Cellular Tissue and Gene Therapies Advisory Committee
March 29–30, July 26–27, November 15–16.
3014512389
Transmissible Spongiform
Encephalopathies Advisory Committee to be announced.
3014512392
Vaccines and Related Biological Advisory Committee
February 27–28, May 16–17, September 19–20,
November 14–15.
3014512391
March 29.
3014512529
pwalker on PROD1PC69 with NOTICES
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs Advisory Committee
VerDate Aug<31>2005
18:15 Dec 28, 2006
Jkt 211001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\29DEN1.SGM
29DEN1
78444
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Notices
TABLE 1.—Continued
Committee Name
Tentative Date(s) of Meeting(s)
Advisory Committee
10–Digit Information
Line Code
Anti Infective Drugs Advisory Committee
April 11–12.
3014512530
Antiviral Drugs Advisory Committee
April, August day(s) to be announced.
3014512531
Arthritis Advisory Committee
April 12.
3014512532
Cardiovascular and Renal Health Advisory Committee
April 17–18, August 21–22, October 16–17, December 11–12.
3014512533
Dermatologic and Ophthalmic Drugs Advisory Committee
To be announced.
3014512534
Drug Safety and Risk Management Advisory Committee
To be announced.
3014512535
Endocrinologic and Metabolic Drugs Advisory Committee
June 13–14, September 5–6, November 13–14.
3014512536
Gastrointestinal Drugs Advisory Committee
To be announced.
3014512538
Nonprescription Drugs Advisory Committee
March, April day (s) to be announced.
3014512541
Oncologic Drugs Advisory Committee
March 28–29, June 1, September 11–12, December 4–5.
3014512542
Peripheral and Central Nervous System Drugs
June 18–20, September 13–14.
3014512543
Pharmaceutical for Science, Advisory Committee for
April, May day(s) to be announced.
3014512539
Psychopharmacologic Drugs Advisory Committee
March, April, September, October day(s) to be announced.
3014512544
Pulmonary Allergy Drugs Advisory Committee
May day(s) to be announced.
3014512545
Reproductive Health Drugs, Advisory Committee for
January 23–24.
3014512537
Device Good Manufacturing Practice Advisory Committee
July 18.
3014512398
Medical Devices Advisory Committee (Comprised of 18 Panels)
Anesthesiology and Respiratory Therapy Devices Panel
October 9–10.
3014512624
Circulatory System Devices Panel
March 1–2, May 22–23, July 17–18, September
18–19, November 13–14.
3014512625
Clinical Chemistry and Clinical Toxicology Devices Panel
June 12–13, September 13–14, December 4–5.
3014512514
Dental Products Panel
February 14, June 6, August 29, November 7.
3014512518
Ear, Nose, and Throat Devices Panel
April 24–25, June 14–15 August 14–15, October
18–19, December 11–12.
3014512522
Gastroenterology-Urology Devices Panel
May 11, July 20, October 19.
3014512523
General and Plastic Surgery Devices Panel
May 8–9, September 20–21, December 6–7.
3014512519
General Hospital and Personal Use Devices Panel
April 3–4, September 26–27.
3014512520
Hematology and Pathology Devices Panel
April 27, October 19.
3014512515
Immunology Devices Panel
July 12, October 17.
3014512516
Medical Devices Dispute Resolution Panel
Meeting Scheduled as Needed.
3014510232
Microbiology Devices Panel
June 26–27, October 23–24.
3014512517
Molecular and Clinical Genetics Panel
April 12, October 11.
3014510231
Neurological Devices Panel
January 26, June 7–8, August 16–17, November
1–2.
3014512513
Obstetrics and Gynecology Devices Panel
May 17–18, August 2–3, October 25–26, December 13–14.
3014512524
pwalker on PROD1PC69 with NOTICES
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
VerDate Aug<31>2005
18:15 Dec 28, 2006
Jkt 211001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\29DEN1.SGM
29DEN1
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Notices
78445
TABLE 1.—Continued
Committee Name
Tentative Date(s) of Meeting(s)
Advisory Committee
10–Digit Information
Line Code
Ophthalmic Devices Panel
May 24–25, July 12–13, October 2–3, November
29–30.
3014512396
Orthopaedic and Rehabilitation Devices Panel
February 22–23, March 27–28, May 22–23, July
17–18 September 18–19. November 13–14
3014512521
Radiological Devices Panel
May 15, August 21, November 13.
3014512526
National Mammography Quality Assurance Advisory Committee
May 21–22.
3014512397
Technical Electronic Product Radiation Safety Standards Committee
September 19.
3014512399
May 1–2, September 25–26.
3014510564
Veterinary Medicine Advisory Committee
September 7.
3014512548
National Center for Toxicological Research (NCTR)
September day(s) to be announced.
3014512559
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory Committee
CENTER FOR VETERINARY MEDICINE
Dated: December 22, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E6–22389 Filed 12–28–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; Genetic Studies in a Cohort
of U.S. Radiologic Technologists
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute, the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
pwalker on PROD1PC69 with NOTICES
Proposed Collection
Title: Genetic Studies in a Cohort of
U.S. Radiologic Technologists (formerly
known as ‘‘Generic Clearance to Collect
Medical Outcome and Risk Factor Data
from a Cohort of U.S. Radiologic
Technologists’’).
Type of Information Collection
Request: Renewal with change of a
previously approved collection (OMB
No. 0925–0405, expiration 02/28/2007).
VerDate Aug<31>2005
18:15 Dec 28, 2006
Jkt 211001
Need and Use of Information
Collection: The primary aim of this
collection is to substantially increase
knowledge about the possible modifying
role of genetic variation on the longterm health effects associated with
protracted low-to moderate-dose
radiation exposures. With this
submission, the NIH, Office of
Communications and Public Liaison,
seeks to obtain OMB’s approval to
collect biospecimens and risk factor
data in this ongoing cohort study of U.S.
radiologic technologists to assess
genetic and molecular risk factors for
cancer, and to evaluate possible
modifying effects of genetic variation on
radiation-cancer relationships.
Researchers at the National Cancer
Institute and The University of
Minnesota have followed a nationwide
cohort of 146,000 radiologic
technologists since 1982, of whom
110,000 completed at least one of three
prior questionnaire surveys and 18,400
are deceased. This cohort is unique
because estimates of cumulative
radiation dose to specific organs (e.g.
breast) are available and the cohort is
largely female, offering a rare
opportunity to study effects of low-dose
radiation exposure on breast and
thyroid cancers, the two most sensitive
organ sites for radiation carcinogenesis
in women. Overall study objectives are:
(1) To quantify radiation dose-response
for cancers of the breast, thyroid, and
other radiogenic sites, and selected
benign conditions related to cancer (e.g.
thyroid nodules); (2) to assess cancer
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
risk associated with genotypic,
phenotypic, or other biologically
measurable factors (e.g. serum levels of
C-reactive protein, insulin growth
factors or binding proteins); and (3) to
determine if genetic variation modifies
the radiation-related cancer risk. A third
follow-up of this cohort was completed
during the past three years. During
2003–2005, the ‘‘Third Survey’’
questionnaire was mailed or
administered by telephone to 101,694
living cohort members who had
completed at least one prior survey;
73,838 technologists (73% response)
completed the survey. The
questionnaire elicited information on:
Medical outcomes to assess radiationrelated risks; detailed employment data
to refine the occupational radiation dose
estimates; and behavioral and
residential histories for estimating
lifetime ultraviolet (UV) radiation
exposure. Analyses of these data are
currently underway and findings will
address an important gap in the
scientific understanding of radiation
dose-rate effects, i.e., whether
cumulative exposures of the same
magnitude have the same health effects
when received in a single or a few doses
over a very short period of time (as in
the atomic bomb or therapeutic
exposures) or in many small doses over
a protracted period of time (as in
medical or nuclear occupational
settings).
There are few, if any, other study
populations in which both quantified
breast radiation doses and blood
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 71, Number 250 (Friday, December 29, 2006)]
[Notices]
[Pages 78443-78445]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-22389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative Schedule of Meetings for 2007
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a
tentative schedule of forthcoming meetings of its public advisory
committees for 2007. During 1991, at the request of the Commissioner of
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM)
conducted a study of the use of FDA's advisory committees. In its final
report, one of the IOM's recommendations was for the agency to publish
an annual tentative schedule of its meetings in the Federal Register.
This publication implements the IOM's recommendation.
FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF-4), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner,
undertook a study of the use of FDA's advisory committees. In its final
report in 1992, one of the IOM's recommendations was for FDA to adopt a
policy of publishing an advance yearly schedule of its upcoming public
advisory committee meetings in the Federal Register; FDA has
implemented this recommendation. The annual publication of tentatively
scheduled advisory committee meetings will provide both advisory
committee members and the public with the opportunity, in advance, to
schedule attendance at FDA's upcoming advisory committee meetings.
Because the schedule is tentative amendments to this notice will not be
published in the Federal Register. However, changes to the schedule
will be posted on the FDA advisory committees' Internet site located at
https://www.fda.gov/oc/advisory/default.htm. FDA will continue to
publish a Federal Register notice 15 days in advance of each upcoming
advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory
committee meetings for 2007. You may also obtain up-to-date information
by calling the Advisory Committee Information Line, 1-800-741-8138
(301-443-0572 in the Washington, DC area).
Table 1.
------------------------------------------------------------------------
Advisory Committee
Committee Name Tentative Date(s) of 10-Digit Information
Meeting(s) Line Code
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
Pediatric Advisory April day(s) to be 8732310001
Committee announced.
------------------------------------------------------------------------
Science Board to the Food June day(s) to be 3014512603
and Drug Administration announced.
------------------------------------------------------------------------
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
Allergenic Products April 18, October 19. 3014512388
Advisory Committee
------------------------------------------------------------------------
Blood Products Advisory April 26-27, August 16- 3014519516
Committee 17, December 13-14.
------------------------------------------------------------------------
Cellular Tissue and Gene March 29-30, July 26- 3014512389
Therapies Advisory 27, November 15-16.
Committee
------------------------------------------------------------------------
Transmissible Spongiform Encephalopathies 3014512392
Advisory Committee to
be announced.
------------------------------------------------------------------------
Vaccines and Related February 27-28, May 16- 3014512391
Biological Advisory 17, September 19-20,
Committee November 14-15.
------------------------------------------------------------------------
CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
Anesthetic and Life March 29. 3014512529
Support Drugs Advisory
Committee
------------------------------------------------------------------------
[[Page 78444]]
Anti Infective Drugs April 11-12. 3014512530
Advisory Committee
------------------------------------------------------------------------
Antiviral Drugs Advisory April, August day(s) 3014512531
Committee to be announced.
------------------------------------------------------------------------
Arthritis Advisory April 12. 3014512532
Committee
------------------------------------------------------------------------
Cardiovascular and Renal April 17-18, August 21- 3014512533
Health Advisory Committee 22, October 16-17,
December 11-12.
------------------------------------------------------------------------
Dermatologic and To be announced. 3014512534
Ophthalmic Drugs Advisory
Committee
------------------------------------------------------------------------
Drug Safety and Risk To be announced. 3014512535
Management Advisory
Committee
------------------------------------------------------------------------
Endocrinologic and June 13-14, September 3014512536
Metabolic Drugs Advisory 5-6, November 13-14.
Committee
------------------------------------------------------------------------
Gastrointestinal Drugs To be announced. 3014512538
Advisory Committee
------------------------------------------------------------------------
Nonprescription Drugs March, April day (s) 3014512541
Advisory Committee to be announced.
------------------------------------------------------------------------
Oncologic Drugs Advisory March 28-29, June 1, 3014512542
Committee September 11-12,
December 4-5.
------------------------------------------------------------------------
Peripheral and Central June 18-20, September 3014512543
Nervous System Drugs 13-14.
------------------------------------------------------------------------
Pharmaceutical for April, May day(s) to 3014512539
Science, Advisory be announced.
Committee for
------------------------------------------------------------------------
Psychopharmacologic Drugs March, April, 3014512544
Advisory Committee September, October
day(s) to be
announced.
------------------------------------------------------------------------
Pulmonary Allergy Drugs May day(s) to be 3014512545
Advisory Committee announced.
------------------------------------------------------------------------
Reproductive Health Drugs, January 23-24. 3014512537
Advisory Committee for
------------------------------------------------------------------------
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
Device Good Manufacturing July 18. 3014512398
Practice Advisory
Committee
------------------------------------------------------------------------
Medical Devices Advisory October 9-10. 3014512624
Committee (Comprised of
18 Panels) Anesthesiology
and Respiratory Therapy
Devices Panel
------------------------------------------------------------------------
Circulatory System Devices March 1-2, May 22-23, 3014512625
Panel July 17-18, September
18-19, November 13-
14.
------------------------------------------------------------------------
Clinical Chemistry and June 12-13, September 3014512514
Clinical Toxicology 13-14, December 4-5.
Devices Panel
------------------------------------------------------------------------
Dental Products Panel February 14, June 6, 3014512518
August 29, November
7.
------------------------------------------------------------------------
Ear, Nose, and Throat April 24-25, June 14- 3014512522
Devices Panel 15 August 14-15,
October 18-19,
December 11-12.
------------------------------------------------------------------------
Gastroenterology-Urology May 11, July 20, 3014512523
Devices Panel October 19.
------------------------------------------------------------------------
General and Plastic May 8-9, September 20- 3014512519
Surgery Devices Panel 21, December 6-7.
------------------------------------------------------------------------
General Hospital and April 3-4, September 3014512520
Personal Use Devices 26-27.
Panel
------------------------------------------------------------------------
Hematology and Pathology April 27, October 19. 3014512515
Devices Panel
------------------------------------------------------------------------
Immunology Devices Panel July 12, October 17. 3014512516
------------------------------------------------------------------------
Medical Devices Dispute Meeting Scheduled as 3014510232
Resolution Panel Needed.
------------------------------------------------------------------------
Microbiology Devices Panel June 26-27, October 23- 3014512517
24.
------------------------------------------------------------------------
Molecular and Clinical April 12, October 11. 3014510231
Genetics Panel
------------------------------------------------------------------------
Neurological Devices Panel January 26, June 7-8, 3014512513
August 16-17,
November 1-2.
------------------------------------------------------------------------
Obstetrics and Gynecology May 17-18, August 2-3, 3014512524
Devices Panel October 25-26,
December 13-14.
------------------------------------------------------------------------
[[Page 78445]]
Ophthalmic Devices Panel May 24-25, July 12-13, 3014512396
October 2-3, November
29-30.
------------------------------------------------------------------------
Orthopaedic and February 22-23, March 3014512521
Rehabilitation Devices 27-28, May 22-23,
Panel July 17-18 September
18-19. November 13-14
------------------------------------------------------------------------
Radiological Devices Panel May 15, August 21, 3014512526
November 13.
------------------------------------------------------------------------
National Mammography May 21-22. 3014512397
Quality Assurance
Advisory Committee
------------------------------------------------------------------------
Technical Electronic September 19. 3014512399
Product Radiation Safety
Standards Committee
------------------------------------------------------------------------
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
Food Advisory Committee May 1-2, September 25- 3014510564
26.
------------------------------------------------------------------------
CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
Veterinary Medicine September 7. 3014512548
Advisory Committee
------------------------------------------------------------------------
National Center for September day(s) to be 3014512559
Toxicological Research announced.
(NCTR)
------------------------------------------------------------------------
------------------------------------------------------------------------
Dated: December 22, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-22389 Filed 12-28-06; 8:45 am]
BILLING CODE 4160-01-S
